InvestorsHub Logo

Tony53711

12/21/23 9:47 AM

#8788 RE: Gwinner #8787

I got the product without any delays or issues. Looking at social media, I do not see where any insiders or company staff are liking or sharing posts which is disappointing.

https://www.bloomberg.com/news/articles/2023-12-21/surging-jn-1-variant-in-wastewater-spurs-questions-about-covid-gut-tropism?embedded-checkout=true

New Covid variant seems to be impacting gut more than previous variants. Little doubt in my mind Zivo had a product to prevent and mitigate effects of Covid given its results impacting inflammation and gut health. Damned near criminal the company never pursued Covid funds or a partner to market a Covid therapeutic in 2020/2021

Amigo Mike

12/21/23 10:16 AM

#8790 RE: Gwinner #8787

s Gwinner,

Every product candidate more or less has basic protocols that need to be done and proven in order for big pharma to take a look. Some more than others. In this case my understanding is that potential partners required these studies along with all the prior data of course.

As far as putting a "book" together ...... John Payne is a member of the "book".

John B. Payne
President / Chief Executive Officer / Chairman of the Board

Mr. Payne was the founder of Compassion-First Pet Hospitals, and served as President and CEO from 2014 until 2020. Compassion-First Pet Hospitals, now NVA Compassion-First, is a family of specialty and emergency veterinary hospitals located throughout the United States that is dedicated to changing the veterinary landscape and elevating patient outcomes. Mr. Payne currently serves as Vice Chairman of National Veterinary Associates, with which Compassion-First Pet Hospitals combined. Prior to founding Compassion-First, Mr. Payne served as a member of the Global Leadership Team for Mars Pet Care. He also served as President and CEO of Banfield Pet Hospitals and as President and General Manager of Bayer Healthcare’s North American Animal Health Division.

Mr. Payne currently serves as Chairman of the Board for American Humane and as Vice Chairman of the Board of Regents at Ross University School of Medicine and School of Veterinary Medicine. He served on the Board of Directors of Nexvet, a bioscience company located in Dublin, Ireland, through the company’s acquisition by Zoetis in 2018.

He's the one with the golden rolodex. He has been a top CEO in animal health arena ...... Bayer Animal Health CEO ....

My understanding is he has direct line to pretty much all the CEOs of major animal pharmas ........ and I've already linked him directly to top execs at Zoetis (prior working together).
Amigo MIke